论文部分内容阅读
目的探讨彩色多普勒(简称彩超)超声造影对胃癌的诊断价值。方法 2009年1月～2011年12月临床诊断胃癌的患者57例,术前均进行了常规彩超检查,口服有回声的造影剂后进行彩超检查,以手术和病理诊断为标准,结合临床分析超声造影的诊断价值。结果 57例口服造影剂彩超诊断胃癌51例,符合率89.5%,普通腹部彩超诊断16例,显示率为28.1%,差异有统计学意义(P<0.01)。结论口服造影剂能够消除胃内气体及粘液的干扰,提高胃癌的显示率及诊断的准确性。
Objective To investigate the diagnostic value of color Doppler (abbreviated as color ultrasound) contrast-enhanced ultrasound in gastric cancer. Methods A total of 57 patients with clinical diagnosis of gastric cancer from January 2009 to December 2011 were routinely performed color Doppler ultrasound examinations. Echocardiography was performed after oral administration of color contrast echocardiography. The standard of operation and pathological diagnosis was combined with clinical analysis of ultrasound. The diagnostic value of angiography. Results Fifty-seven cases were diagnosed with color Doppler ultrasonography by contrast-enhanced colorimetry, and the coincidence rate was 89.5%. 16 cases were diagnosed by common abdominal color Doppler ultrasound. The display rate was 28.1%, and the difference was statistically significant (P<0.01). Conclusion Oral contrast agent can eliminate gas and mucus interference in stomach, improve the display rate of gastric cancer and the accuracy of diagnosis.